Monday, 5 October 2015

FDA approves Optune for NEWLY DIAGNOSED glioblastoma

Al already sent this out on the news blast and I just did an update on Astrocytoma Options, but here it is again:

FDA Approves Optune in Combination with Temozolomide for theTreatment of Newly Diagnosed Glioblastoma

First therapy to be approved for newly diagnosed GBM since TMZ was approved on March 15, 2005.

1 comment:

  1. This is truly fantastic. I am going to be looking into this for my Mum when I return to the UK next week. I believe it is available in London at the Cromwells hospital. Thank you Stephen for the update.

    ReplyDelete